ODC enters its fiscal third-quarter earnings call today with a notable tailwind at its back: the stock has climbed more than 8% over the past month to $83.99, a move that now demands justification from the results.
The borrow market tells a relaxed story heading into the print. Short interest runs at roughly 3.1% of the free float — modest by any measure — and borrow availability is extraordinarily loose, with more than 40 shares available to borrow for every one currently lent out. Cost to borrow has crept higher over the past month, up roughly 43% to 0.87%, but the absolute level remains very low. None of this signals meaningful short-seller conviction. The ORTEX short score of 38.6 sits in the 41st percentile, consistent with a stock where the borrow market is barely a factor. What's more notable in the short interest history is a sharp reduction in mid-May, when shares short fell from roughly 443,000 to around 210,000 in a single period — suggesting a partial cover event that preceded much of the recent price rally.
The bull case for ODC rests on structural demand. Cat litter and agricultural absorbents are defensive, repeat-purchase categories. The stock's ORTEX momentum score was running above 80 in recent weeks, underpinned by persistent price strength relative to the broader market. The bear case is simpler: valuation. At a price-to-earnings multiple around 16.75x and price-to-book near 3.2x, the stock no longer looks cheap after a 49%-plus year-to-date run through mid-April, and the most recent earnings history shows the market has not been forgiving — the March 2026 print produced a 1-day decline of about 2% and a 5-day drop approaching 7%, while the prior quarter saw a 1-day fall of nearly 5% and a 5-day move of roughly minus 8.5%. Both recent prints resolved to the downside over the following week.
Institutional ownership is concentrated and largely passive. CEO Daniel Jaffee holds nearly 7.6% of shares, and the insider flow over the past 90 days has been modestly net positive in share count, though the most notable recent trade — a director sale in late April near $73 — came well below the current price. Most of the seller activity from insiders took place in October 2025 below $60, meaning insiders who reduced positions early have watched the stock move significantly higher since. Peers — including PG, CLX, and CHD — all moved higher on the day, with Clorox up more than 5% and Procter & Gamble adding 4%, suggesting a broad sector bid that has also lifted ODC.
Today's print will test whether the fundamental story — volumes, pricing, and margin trajectory in absorbent minerals — can sustain a valuation that has expanded sharply into a sector where recent earnings have consistently sent the stock lower in the days that followed.
See the live data behind this article on ORTEX.
Open ODC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
